https://www.selleckchem.com/pr....oducts/talabostat.ht
During 47-month follow-up, 32 deaths and 72 CHF occurred. Event-free rate was 14%, 48%, and 93% in patients with severe, moderate, and mild TR, respectively. Severe TR was graded as VCavg 6 mm, EROA 0.30 cm2, RegVol 30 mL, and RegF 45%. This outcome study demonstrates the prognostic value of quantitative parameters of TR severity and provides prognostically meaningful threshold values to grade TR severity in low, intermediate, and high risk. This outcome study demonstrates the prognostic value of quantitative para
पसंद करना
टिप्पणी
शेयर करना
